Masimo Corporation (NASDAQ: MASI) Q2 2025 Earnings | 08/06/2025

About this video

Masimo Corporation reported strong Q2 2025 results, with total revenue reaching $370.9 million, marking an 8% increase year-over-year. The company achieved a non-GAAP earnings per share (EPS) of $1.33, representing 46% growth compared to the prior year and surpassing consensus estimates. GAAP EPS rose to $0.82, up 78.3% from $0.46 in Q2 2024. Gross profit increased 12.5% to $233.3 million, with a gross margin expansion of 262 basis points to 62.9%. Selling, general, and administrative expenses increased 9.9% to $138.9 million, while research and development expenses decreased 23.5% to $29.9 million. Adjusted operating profit surged 53.9% to $64.5 million, representing an adjusted operating margin of 17.4%, up 521 basis points year-over-year. Masimo's revenue growth was driven by increased consumable sales, offset by a decline in capital equipment revenues. The shipments of non-invasive technology boards and instruments, excluding handheld and fingertip pulse oximeters, totaled 63,100 units—a 7.7% increase year-over-year. Cash and cash equivalents stood at $149.6 million at quarter-end, while long-term debt decreased to $598.7 million. Operating cash flow was $99.5 million. The company raised its full-year 2025 outlook, expecting total revenues between $1.505 billion and $1.535 billion, an 8-11% increase at constant exchange rates, and adjusted EPS in the range of $5.45 to $5.70, representing growth of 30-36% compared to 2024. Masimo’s strong top and bottom-line performance, margin expansion, and growth in consumable and service revenues underscore its solid operational execution and financial health. About Inside Ticker: For more expert analysis and real-time updates on Masimo Corporation (NASDAQ: MASI) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #Masimo #MASI #Q22025 #Earnings #FinancialResults #RevenueGrowth #EPS #GrossMargin #OperatingProfit #Consumables #NonInvasiveTech #Healthcare #MedicalDevices #CashFlow #DebtReduction #NASDAQ #InsideTicker #2025Outlook #InvestorUpdate #MedicalTechnology #R&D #OperationalExcellence